Lenzilumab
Product Specifications
CAS Number
1229575-09-0
Target
C-Fms, SARS-CoV
Related Pathways
Microbiology/Virology, Tyrosine Kinase/Adaptors
Purity
0.989
Bioactivity
Lenzilumab (KB 003) is a humanized granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibody that directly binds to GM-CSF and prevents signaling through its receptor, and can be used to study COVID-19.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E-CL-H0560-01 24 Tests
Human COL6α1 (Collagen Type VI Alpha 1) CLIA Kit
Sign In for Pricing
View Details E-CL-H0560-02 48 Tests
Human COL6α1 (Collagen Type VI Alpha 1) CLIA Kit
Sign In for Pricing
View Details E-CL-H0560-03 96 Tests
Human COL6α1 (Collagen Type VI Alpha 1) CLIA Kit
Sign In for Pricing
View Details 
BNC550028-100 1x 100 µL
CD45RA (158-4D3), CF555 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881597-100 1x 100 µL
IL-4 / Interleukin 4 (IL4/1597), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400773-100 1x 100 µL
CD20 (IGEL/773), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details